Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115246807B reveals a novel Pd-catalyzed route for thioester compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113307778A reveals a mild Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering reliable pharmaceutical intermediate supply and cost reduction.
Patent CN111675662B reveals a cost-effective iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant supply chain advantages for pharmaceutical intermediates.
Novel patent CN114195711B offers efficient quinoline-4(1H)-one synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method using benzyl formate. High yields, mild conditions, scalable process for pharmaceutical intermediates.
Novel synthesis method offers mild conditions and high yield for pharmaceutical intermediates ensuring cost reduction and supply chain reliability for global partners seeking advanced antitumor solutions
Novel isoindolone-based antitumor compound synthesis offers mild conditions and high yield for reliable pharmaceutical intermediate supply chains.
Patent CN111423381A details a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply with enhanced metabolic stability.
Novel Pd-catalyzed carbonylation method offers high yields and broad substrate scope for cost-effective pharmaceutical intermediate manufacturing.
Patent CN109096186B reveals a green ultrasound-assisted aqueous synthesis for 2-arylsulfonyl quinolines, offering significant cost reduction in API manufacturing and superior purity.
Patent CN113105402B details a metal-free iodine-promoted synthesis of trifluoromethyl triazoles, offering significant cost reduction and simplified supply chains for API manufacturing.
Patent CN111253293B reveals efficient iron-catalyzed synthesis. Delivers high-purity intermediates with significant cost reduction in pharmaceutical manufacturing.
Patent CN112239436A details a safe, one-step synthesis of bioactive furanones using solid CO sources, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN108623496B reveals a safe, scalable route for 3-ethyl-4-fluorobenzonitrile, eliminating toxic tin reagents for cost-effective API manufacturing.
Patent CN113549062A discloses bulky chiral quaternary ammonium salts enhancing enantioselectivity in KMnO4 oxidation, offering cost-effective API intermediate solutions.
Patent CN116813544B reveals metal-free heating method for 2-trifluoromethyl quinoline. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111675662B reveals a novel FeCl3-catalyzed cyclization for 2-trifluoromethyl quinazolinones, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN115353511A details a novel Pd-catalyzed multi-component synthesis for carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and scalable production.
Novel synthesis method for chiral indolo compounds with high enantioselectivity. Cost-effective manufacturing for pharmaceutical applications ensuring supply chain reliability.
Novel Pd-catalyzed carbonylation method using solid CO source offers safe, scalable production of high-purity pharmaceutical intermediates with broad substrate tolerance.